Market Place
Sourcing Support
Cadrenal Therapeutics Reports Full Year 2024 Results and Business
13 Mar 2025 //
BUSINESSWIRE
Cadrenal, Abbott Partner For Tecarfarin Study In HeartMate 3™ LVAD
04 Mar 2025 //
BUSINESSWIRE
Cadrenal Therapeutics Reinforces Clinical Plan for Tecarfarin
31 Dec 2024 //
BUSINESSWIRE
Cadrenal Therapeutics Raises $5.1 Million Via Market Facility
24 Oct 2024 //
PR NEWSWIRE
Cadrenal And Abbott Collaborate On Tecarfarin For LVAD Patients
06 Aug 2024 //
PR NEWSWIRE
Cadrenal Engages The Sage Group to Advance Tecarfarin`s Late-Stage Development
12 Dec 2023 //
PR NEWSWIRE
Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist
05 Sep 2023 //
PR NEWSWIRE
Cadrenal Therapeutics Expands Focus for Tecarfarin
01 Aug 2023 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.